Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

US Patent 9861630 · Granted Jan 9, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulations/compositions comprising ibrutinib2025
Crystalline forms of a MAGL inhibitor2024
1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2022
1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2022
1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2022
Vortioxetine pyroglutamate2022
Vortioxetine pyroglutamate2019
Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperaz2018
Methods for the preparation of 1,3-benzodioxole heterocyclic compounds2018
Method of administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trime2017
Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazi2016
Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine2016